Loading…
Intellia Therapeutics, Inc. is projected to rise to $16.90 by 2027, a +19% move from its current price of $14.22. NTLA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $13.63 | $14.23 | $14.85 | +0.08% |
| Jul 15 | $13.40 | $14.24 | $15.13 | +0.16% |
| Jul 16 | $13.23 | $14.25 | $15.34 | +0.24% |
| Jul 17 | $13.09 | $14.26 | $15.53 | +0.33% |
| Jul 18 | $12.97 | $14.27 | $15.70 | +0.41% |
| Jul 19 | $12.87 | $14.28 | $15.86 | +0.49% |
| Jul 20 | $12.77 | $14.30 | $16.01 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.77 | $14.30 | $16.01 | +0.57% |
| Week 2 | $12.25 | $14.38 | $16.87 | +1.15% |
| Week 3 | $11.89 | $14.46 | $17.59 | +1.72% |
| Week 4 | $11.60 | $14.54 | $18.23 | +2.31% |
| Week 5 | $11.36 | $14.63 | $18.83 | +2.89% |
| Week 6 | $11.15 | $14.71 | $19.40 | +3.48% |
| Week 7 | $10.97 | $14.79 | $19.95 | +4.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Intellia Therapeutics, Inc. is a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies. It offers a modular platform to advance in vivo and ex vivo therapies for diseases, and its in vivo product candidates include NTLA-2001 for the treatment of transthyretin amyloidosis and NTLA-2002 for hereditary angioedema.
The company was formerly known as AZRN, Inc., was incorporated in 2014, and is headquartered in Cambridge, Massachusetts.
NTLA trades at $14.22, with a market cap of $1.99B, and ranks 2047 in market capitalization. The stock sits near its 50-day moving average at $14.28 and above its 200-day moving average at $13.72, indicating a price relationship to its short- and medium-term trend. The thirty-day price range runs from $10.73 to $18.84, and the annualized volatility stands at 80%.
The current sentiment is NEUTRAL. The long-range forecast shows upside potential, with the avg price rising over time and notable ROIs in later years, including $17.85 by 2030 (ROI 25.6%), $49.09 by 2040 (ROI 245.3%), and $77.77 by 2050 (ROI 447.1%).
A major floor 36.7% below — a decisive break under it would weaken the trend.
The nearest floor, 14.8% below — buyers have tended to step in here.
The nearest ceiling, 25.5% above — a clean break opens room to run.
A major ceiling 43.9% above — clearing it would confirm fresh momentum.
Key NTLA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NTLA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.35 | Sell | $15.80 | Sell |
| MA 10 | $16.68 | Sell | $16.10 | Sell |
| MA 20 | $15.71 | Sell | $15.72 | Sell |
| MA 50 | $14.28 | Sell | $14.77 | Sell |
| MA 100 | $13.94 | Buy | $14.07 | Buy |
| MA 200 | $13.72 | Buy | $13.56 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.20 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -83.86 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.20 | Sell |
| ROC (12) | -6.79 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.84 | Buy |
| Awesome (5,34) | 1.66 | Buy |
| Ultimate (7,14,28) | 30.06 | Neutral |
| Momentum (10) | -1.82 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 15.52 | Sell |
| ADX (14) | 20.66 | Sell |
| ATR (14) | 0.60 | Info |
The 30-day technical picture is NEUTRAL. RSI(14) is 40, suggesting modest momentum. The stock trades around the SMA50 of $14.28 and remains above the SMA200 of $13.72, indicating a constructive but cautious near-term stance. Key near-term levels are support at $12.11 and resistance at $17.84, with the 30-day range spanning $10.73 to $18.84.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.21 | $14.22 | $20.72 | 0% | Neutral | |
| $12.75 | $16.90 | $24.07 | +19% | Neutral | |
| $13.17 | $18.29 | $27.48 | +29% | Bullish | |
| $12.45 | $17.98 | $28.15 | +26% | Bullish | |
| $11.93 | $17.85 | $28.93 | +26% | Bullish | |
| $13.66 | $21.11 | $35.24 | +49% | Bullish | |
| $16.82 | $26.80 | $45.94 | +89% | Bullish | |
| $18.90 | $31.01 | $54.43 | +118% | Bullish | |
| $18.02 | $30.41 | $54.56 | +114% | Bullish | |
| $17.88 | $31.01 | $56.75 | +118% | Bullish | |
| $24.91 | $49.09 | $97.61 | +245% | Bullish | |
| $35.00 | $77.77 | $174.01 | +447% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $9.21 | $14.22 | $17.10 | +0.00% |
| August 2026 | $12.26 | $14.69 | $18.23 | +3.31% |
| September 2026 | $12.63 | $15.31 | $19.33 | +4.25% |
| October 2026 | $12.28 | $15.03 | $19.24 | -1.86% |
| November 2026 | $12.11 | $14.94 | $19.36 | -0.58% |
| December 2026 | $12.72 | $15.82 | $20.72 | +5.88% |
Click any year to see its month-by-month NTLA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NTLA price prediction for 2026 points to an average of $14.22 (low $9.21, high $20.72) — a potential gain of 0% on today's $14.22. Price action looks broadly range-bound.
In 2027, NTLA is projected to trade between $12.75 and $24.07, averaging $16.90 — a potential gain of +19% from today's $14.22. That is up +19% on the projected 2026 average. A consolidation phase looks the most probable path here.
Intellia Therapeutics, Inc.'s 2028 outlook centres on $18.29, within a $13.17 to $27.48 range. That is up +8% on the projected 2027 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2029, NTLA could reach as high as $28.15, with a base case around $17.98 and support toward $12.45 — roughly +26% from $14.22. Buyers look set to stay in control over this stretch.
Expect NTLA to range from $11.93 to $28.93 through 2030. The $17.85 average target implies a +26% move from current prices. That is -1% versus the projected 2029 average. Momentum favours further upside here.
The NTLA price prediction for 2031 points to an average of $21.11 (low $13.66, high $35.24) — a potential gain of +49% on today's $14.22. Buyers look set to stay in control over this stretch.
In 2032, NTLA is projected to trade between $16.82 and $45.94, averaging $26.80 — a potential gain of +89% from today's $14.22. That is up +27% on the projected 2031 average. Momentum favours further upside here.
Intellia Therapeutics, Inc.'s 2033 outlook centres on $31.01, within a $18.90 to $54.43 range. That is up +16% on the projected 2032 average. That marks a +118% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NTLA could reach as high as $54.56, with a base case around $30.41 and support toward $18.02 — roughly +114% from $14.22. Momentum favours further upside here.
Expect NTLA to range from $17.88 to $56.75 through 2035. The $31.01 average target implies a +118% move from current prices. That is up +2% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The NTLA price prediction for 2040 points to an average of $49.09 (low $24.91, high $97.61) — a potential gain of +245% on today's $14.22. Momentum favours further upside here.
In 2050, NTLA is projected to trade between $35.00 and $174.01, averaging $77.77 — a potential gain of +447% from today's $14.22. That is up +58% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NTLA today (≈ 70.348224 NTLA) could be worth
$5,471.29
+$4,471.29 (+447%) by 2050 · US Dollar
Based on the average projected NTLA price of $77.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NTLAwould be worth at today's price.
$1,000 invested in NTLA on Jul 10, 2025 (≈ 82.236843 NTLA) would be worth
$1,169
+$169 (+16.9%) today · 1.17× · US Dollar
Based on a NTLA entry price of $12.16 vs. today's $14.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.56 | $809.51 | -19.0% |
| 1 month ago | $12.2 | $1,165.16 | +16.5% |
| 3 months ago | $13.49 | $1,053.74 | +5.4% |
| 6 months ago | $11.43 | $1,243.66 | +24.4% |
| 1 year ago | $12.16 | $1,169 | +16.9% |
| All time (5.0y) ago | $141.06 | $100.77 | -89.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NTLA forecast.
Our base-case forecast reaches $28.00 around 2033.
Implied market cap at $28.00: $3.91B
The multi-year forecast indicates a bullish trajectory beginning in 2028 and continuing through 2050. 2030 is projected with an avg price of $17.85 and ROI of 25.6%, while 2040 shows a much higher avg price of $49.09 with ROI of 245.3%, and 2050 projects an avg of $77.77 with ROI of 447.1%. The sentiment rises to BULLISH from 2028 onward and remains so through 2050.
The forecast implies substantial longer-term upside despite near-term volatility, as reflected in an annualized volatility of 80%. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $17.85, Min $11.93, Max $28.93, ROI 25.6%, sentiment BULLISH.
Forecasts show bullish potential in later years, with 2040 avg $49.09 (ROI 245.3%) and 2050 avg $77.77 (ROI 447.1%), but these are estimates and not guarantees.
Yes, the 2050 max forecast is $174.01, which exceeds $100.
Current price $14.22; Market cap $1.99B.
30-day range is $10.73 to $18.84. Support is $12.11 and resistance is $17.84.
Intellia Therapeutics, Inc. Community Discussion
0Share your Intellia Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.